We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Peptide Mix Makes HIV Self-Destruct in a Petri Dish

By LabMedica International staff writers
Posted on 07 Sep 2010
A new study describes a peptide cocktail that causes apoptotic cell death of HIV infected cells, with total extermination of the virus.

Researchers at the Hebrew University (Jerusalem, Israel) developed a novel approach to eradicate HIV-1 infected cells specifically and significantly, as well as to eliminate infectious virions from cultured cells. More...
The process involves the stimulation of viral integrase (IN) enzymatic activity by the IN derived-integrase stimulatory (INS) peptide and IN derived-Rev interacting (INrs) peptides to disrupt the IN complex, combined with the prevention of virion production by the protease inhibitor Ro 31-8959.

The researchers found a correlation between increase in the integration of HIV-1 cDNA and cell death, showing that the combination of peptides that stimulate integration, together with the protease inhibitor caused apoptotic cell death of the HIV infected cells. This combination did not have any effect on noninfected cells, appearing to promote cell death only in infected cells. The researchers suggest that the results could provide a novel approach to promote the death of HIV-1 infected cells specifically, and may eventually be developed into a new and general antiviral therapy. The study was published on august 19, 2010, in Aids Research and Therapy, a publication of Biomed Central.

"Whilst this research is promising, a major caveat with these studies is that they are preliminary,” said lead author Abraham Loyter, Ph.D., of the department of biological chemistry. "So far these experiments have only been shown to 'cure' HIV from small dishes of cultured cells in the authors' laboratory, but the findings are an exciting development in the quest to eradicate this devastating global pandemic.”

A virion consists of a complete virus particle, composed of nucleic acid surrounded by a protective coat of protein called a capsid; these are formed from identical protein subunits called capsomers. One of the problems with battling HIV is that it evades the immune system by constantly changing the amino acid sequence of the proteins on the surface of the virion.

Since most viruses cannot be seen with a light microscope, scanning and transmission electron microscopes are used to visualize the virion.

Related Links:

Hebrew University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Hematology Consumables
Bioblood Devices
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.